• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视儿童二尖瓣置换术中的假体选择:传统生物假体的耐用替代品。

Revisiting prosthesis choice in mitral valve replacement in children: Durable alternatives to traditional bioprostheses.

作者信息

Choi Perry S, Sleeper Lynn A, Lu Minmin, Upchurch Patrick, Baird Christopher, Emani Sitaram M

机构信息

Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, , Boston, Mass.

Department of Cardiology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.

出版信息

J Thorac Cardiovasc Surg. 2020 May 31. doi: 10.1016/j.jtcvs.2020.04.173.

DOI:10.1016/j.jtcvs.2020.04.173
PMID:32713632
Abstract

OBJECTIVE

To determine risk factors for re-replacement and death or transplant following mitral valve replacement (MVR) in children METHODS: This is a retrospective 26-year review of patients younger than 20 years of age undergoing MVR between 1992 and 2018 at single institution. Outcomes included freedom from re-MVR and transplant-free survival. Cox proportional hazards regression models assessed association between outcomes and potential risk factors.

RESULTS

At median age 4.2 years, 190 children underwent 290 MVR: 180 mechanical, 63 porcine, 13 pericardial, and 34 stented bovine jugular vein valves. Re-MVR occurred in 100 valves. Freedom from re-MVR at 5 and 10 years was 76% and 44%. Times to re-MVR were associated with prosthesis type (P < .001), with porcine and pericardial valves at greatest risk. Other risk factors for prosthetic failure included smaller prosthesis size and left ventricular hypoplasia. There were 9 transplants and 44 deaths. Transplant-free survival at 5 and 10 years was 81% and 76%. Prosthesis type was significantly associated with time to death/transplant in univariate analysis only (P = .021), with porcine at greater risk than mechanical. Independent risk factors for death/transplant included larger indexed geometric orifice area and longer bypass time.

CONCLUSIONS

In pediatric patients undergoing MVR, mechanical and stented bovine jugular vein valves were associated with increased durability compared with fixed-diameter bioprosthetic alternatives.

摘要

目的

确定儿童二尖瓣置换术(MVR)后再次置换以及死亡或移植的危险因素。方法:这是一项对1992年至2018年在单一机构接受MVR的20岁以下患者进行的回顾性26年研究。结局包括无再次二尖瓣置换术和无移植生存。Cox比例风险回归模型评估结局与潜在危险因素之间的关联。

结果

中位年龄4.2岁,190名儿童接受了290次二尖瓣置换术:180次使用机械瓣膜,63次使用猪瓣膜,13次使用心包瓣膜,34次使用带支架的牛颈静脉瓣膜。100个瓣膜发生了再次二尖瓣置换术。5年和10年时无再次二尖瓣置换术的比例分别为76%和44%。再次二尖瓣置换术的时间与假体类型相关(P <.001),猪瓣膜和心包瓣膜风险最高。假体失败的其他危险因素包括假体尺寸较小和左心室发育不全。有9例移植和44例死亡。5年和10年时无移植生存的比例分别为81%和76%。仅在单因素分析中,假体类型与死亡/移植时间显著相关(P = 0.021),猪瓣膜比机械瓣膜风险更高。死亡/移植的独立危险因素包括较大的指数几何开口面积和较长的体外循环时间。

结论

在接受二尖瓣置换术的儿科患者中,与固定直径的生物假体相比,机械瓣膜和带支架的牛颈静脉瓣膜的耐用性更高。

相似文献

1
Revisiting prosthesis choice in mitral valve replacement in children: Durable alternatives to traditional bioprostheses.重新审视儿童二尖瓣置换术中的假体选择:传统生物假体的耐用替代品。
J Thorac Cardiovasc Surg. 2020 May 31. doi: 10.1016/j.jtcvs.2020.04.173.
2
Twenty-year clinical experience with porcine bioprostheses.猪生物瓣膜的二十年临床经验。
Ann Thorac Surg. 1996 Nov;62(5):1301-11; discussion 1311-2. doi: 10.1016/0003-4975(96)00629-7.
3
Late incidence and determinants of reoperation in patients with prosthetic heart valves.人工心脏瓣膜置换术后再次手术的晚期发生率及影响因素
Eur J Cardiothorac Surg. 2004 Mar;25(3):364-70. doi: 10.1016/j.ejcts.2003.12.013.
4
Evolution of mitral valve replacement in children: a 40-year experience.儿童二尖瓣置换术的演变:40 年经验。
Ann Thorac Surg. 2012 Feb;93(2):626-33; discussion 633. doi: 10.1016/j.athoracsur.2011.08.085. Epub 2011 Dec 7.
5
Bovine pericardial versus porcine bioprosthetic mitral valves: results from a Korean Nationwide Cohort Study.牛心包与猪生物二尖瓣瓣膜:来自韩国全国队列研究的结果。
Eur J Cardiothorac Surg. 2023 Jun 1;63(6). doi: 10.1093/ejcts/ezad165.
6
Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?儿童主动脉瓣和二尖瓣置换术:生物及生物人工替代瓣膜有何作用?
Eur J Cardiothorac Surg. 2009 Jul;36(1):84-90; discussion 90. doi: 10.1016/j.ejcts.2009.02.048. Epub 2009 Apr 14.
7
Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement.牛心包与猪生物瓣二尖瓣置换术后结构性瓣膜退变及长期临床结局的比较分析
J Thorac Dis. 2021 Jul;13(7):3969-3978. doi: 10.21037/jtd-21-281.
8
Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years.50 岁至 69 岁患者感染性心内膜炎的生物瓣与机械瓣二尖瓣置换。
Clin Cardiol. 2020 Oct;43(10):1093-1099. doi: 10.1002/clc.23407. Epub 2020 Jun 4.
9
Bioprosthesis in the Mitral Position: Bovine Pericardial versus Porcine Xenograft.二尖瓣位生物瓣膜:牛心包瓣膜与猪异种移植物对比
J Chest Surg. 2022 Feb 5;55(1):69-76. doi: 10.5090/jcs.21.103.
10
Long-term outcomes of valve replacement with modern prostheses in young adults.年轻成年人使用现代人工瓣膜进行瓣膜置换的长期结果。
Eur J Cardiothorac Surg. 2005 Mar;27(3):425-33; discussion 433. doi: 10.1016/j.ejcts.2004.12.002. Epub 2004 Dec 30.

引用本文的文献

1
Single center experience with surgically implanted Melody and Sapien 3 valves in the mitral position in young children.小儿二尖瓣位置手术植入Melody和Sapien 3瓣膜的单中心经验。
Front Cardiovasc Med. 2025 Jun 13;12:1584134. doi: 10.3389/fcvm.2025.1584134. eCollection 2025.
2
Nanocellulose: Recent Advances Toward Biomedical Applications.纳米纤维素:生物医学应用的最新进展
Small Sci. 2022 Dec 22;3(2):2200076. doi: 10.1002/smsc.202200076. eCollection 2023 Feb.
3
The Melody Valve in Small Children Undergoing First Mitral Valve Replacement: Better Than Mechanical?
首次二尖瓣置换术患儿中的旋律瓣膜:比机械瓣膜更好吗?
Ann Thorac Surg Short Rep. 2024 May 6;2(3):359-363. doi: 10.1016/j.atssr.2024.04.016. eCollection 2024 Sep.
4
Options for pediatric heart valve replacement.小儿心脏瓣膜置换的选择。
Future Cardiol. 2025 Jan;21(1):47-52. doi: 10.1080/14796678.2024.2445402. Epub 2025 Jan 9.
5
Challenges and Priorities for Children With Congenital Valvar Heart Disease: The Heart Valve Collaboratory.先天性心脏瓣膜病患儿面临的挑战与优先事项:心脏瓣膜协作组
JACC Adv. 2024 Sep 6;3(10):101191. doi: 10.1016/j.jacadv.2024.101191. eCollection 2024 Oct.
6
Long-term outcomes following mitral valve replacement in children at heart center Leipzig: a 20-year analysis.莱比锡心脏中心行二尖瓣置换术治疗儿童的 20 年长期结果分析。
J Cardiothorac Surg. 2024 Jul 3;19(1):419. doi: 10.1186/s13019-024-02904-7.
7
Risk of infective endocarditis after hybrid melody mitral valve replacement in infants: the French experience.婴儿杂交Melody二尖瓣置换术后感染性心内膜炎的风险:法国的经验
Interdiscip Cardiovasc Thorac Surg. 2024 Mar 29;38(4). doi: 10.1093/icvts/ivae046.
8
Mitral valve replacement in children: balancing durability and risk with mechanical and bioprosthetic valves.儿童二尖瓣置换术:机械瓣膜与生物瓣膜在耐用性和风险之间的权衡
Interdiscip Cardiovasc Thorac Surg. 2024 Mar 5;38(3). doi: 10.1093/icvts/ivae034.
9
Commentary: The antifragility of the Melody valve.评论:旋律瓣膜的反脆弱性。
JTCVS Tech. 2020 Oct 23;4:251-252. doi: 10.1016/j.xjtc.2020.10.020. eCollection 2020 Dec.
10
Mitral valve replacement in infants and younger children.婴儿和幼儿的二尖瓣置换术。
Sci Rep. 2021 Jul 27;11(1):15239. doi: 10.1038/s41598-021-94779-0.